Numerous laboratory tests and imaging methods are available that can be used in @entity1 who are diagnosed with @entity320 . The downside risks related to testing are cost and @entity1 @entity148 . Therefore, it must be critically considered which examinations are useful and feasible. After a diagnosis of primary @entity320 , many physicians in Germany perform lymph node ultrasound to detect occult regional @entity3 . Whole-body imaging techniques, except the physical examination, are unlikely to detect distant occult @entity3 . In @entity5 that have an intermediate or high risk of recurrence (> 1 mm @entity5 thickness), baseline whole-body imaging may serve as a reference for ongoing evaluation. During follow-up care, physical examination alone is appropriate when there is a low risk for recurrence (up to 1-mm @entity5 thickness). In @entity1 whose @entity5 are > 1 mm thickness, regular lymph node ultrasound examinations and determination of serum @entity5 marker @entity4483 protein are commonly used by physicians in Germany. Whole-body imaging techniques are useful in @entity1 who have locoregional and/or distant @entity3 . For consideration of surgical resections in stage IV disease, more advanced examinations techniques such as positron emission tomography-computed tomography or whole body magnetic resonance imaging may be used. Early detection of limited disease using these methods may be helpful for @entity1 who have locoregional metastases and for 10-20% of @entity1 who have distant metastases and whose limited disease may be amenable to surgical resection.

XXXX : baseline and ongoing laboratory evaluation.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity4483 :: ('6285', 'Gene') :: ['S-100beta'] @entity148 :: ('MESH:D001008', 'Disease') :: ['anxiety'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity320 :: ('MESH:D008545', 'Disease') :: ['cutaneous melanoma']
@entity320 :: (MESH:D008545,Disease) :: ['Cutaneous melanoma']
